CLYM · ISSUER CIK 1768446
Climb Bio, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 2 Climb Bio, Inc. insiders reported $0.00 of open-market purchases and $1.4M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.4MInsider selling
−$1.4MNet open-market
Sep 30, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 202616:55 | Sep 28, 2026 | CLYM | Director, 10% Owner · +6 joint | M · Exercise | $2.79 | +70,000 | 70,000 | New | $195K | ||
| Sep 17, 202616:15 | Sep 15, 2026 | CLYM | Director | S · Sell10b5-1 | $13.67 | −100,000 | 467,969 | -18% | −$1.4M |